Innovative Air Purification Project Aims to Revolutionize Healthcare Environments
A collaborative effort between Chalmers University of Technology, Chalmers Industriteknik (CIT), and Region Skåne has secured funding from Formas to continue the Clean Surge Air research project. This initiative, commencing in December 2025, will evaluate LightAir’s patented CellFlow DEP technology within ventilation systems, comparing it against conventional air purification methods. The ultimate goal is to identify alternative technologies that can effectively reduce airborne infection transmission in healthcare facilities.
The project seeks to explore the potential of novel technologies to address the increasing demand for enhanced ventilation in healthcare settings, a need highlighted in recent years by hygiene experts. LightAir’s CellFlow DEP technology will be rigorously assessed and benchmarked against traditional air purification techniques. LightAir will contribute its expertise in air purification and provide specific filter equipment for the study.
This new project builds upon CIT’s previous research, which concluded earlier this year, focused on improving air quality in operating rooms and other healthcare environments. That three-year project, also funded by Formas, aimed to develop effective solutions for cleaner air and demonstrated the efficacy of LightAir’s technology and concepts.
“The electrostatic filters in the air purifiers were crucial for the previous project’s success because they were easy to wash with water and generated minimal pressure drop and noise compared to other types of filters,” says Daniel Olsson, project manager at CIT. “The correlation between air quality and reduced infection risk is directly proportional, making air purification extremely important. Conventional solutions for these needs are relatively expensive, maintenance-intensive, bulky, and also very power-intensive, consuming a lot of energy.”
LightAir’s patented CellFlow DEP technology, incorporated into the company’s industrial offerings, is designed with a focus on purification efficiency, energy consumption, and noise levels.
“We are very pleased to once again be involved in contributing to future projects to demonstrate the possibility of safer healthcare environments with new technology,” says Lars Liljeholm, CEO of LightAir. “Regardless of the environment, we know that our technology has significant advantages compared to conventional solutions. It will be very interesting to follow this project, which will now test LightAir’s technology in various ventilation applications.”
Key Objectives of the Clean Surge Air Project:
- Evaluate LightAir’s CellFlow DEP technology in real-world healthcare settings.
- Compare the technology’s performance against conventional air purification methods.
- Identify alternative technologies for reducing airborne infection transmission.
- Assess the energy efficiency and cost-effectiveness of different solutions.
About LightAir
LightAir AB (publ) is dedicated to improving health and well-being by offering the best solutions for industrial and commercial air purification. Their CellFlow technology and LightAir Connect help businesses create cleaner and safer work environments. The company’s stock is listed on Nordic SME Sweden (Nordic Growth Market NGM AB) under the ticker symbol LAIR.
Enjoyed this post by Thibault Helle? Subscribe for more insights and updates straight from the source.
